GUARDANT HEALTH ANNOUNCES APPROVAL IN EUROPE OF GUARDANT360® CDX AS COMPANION DIAGNOSTIC FOR ASTRAZENECA’S ETCAMAH™ (CAMIZESTRANT) IN ADVANCED ER-POSITIVE BREAST CANCER

Reuters · 2d ago

Please log in to view news